相关实验视频

Updated: Sep 13, 2025

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

生物标志物对动脉疾病和中风的影响

Baofeng Xu¹, Xi Jiang², Haoming Li³

¹Stroke Center, Department of Neurology, The First Hospital of Jilin University, Changchun, China.

Scientific reports

|July 30, 2025

概括

这项研究确定了中风风险的关键生物标志物. C-反应蛋白 (CRP) 和骨质保护蛋白 (OPG) 显示出保护作用,而骨质补丁 (OPN) 和LOX1则表明动脉样硬化患者的风险增加.

科学领域:

生物标志物生物标志物
心血管疾病心血管疾病
神经学神经学

背景情况:

脑卒中是一个主要的健康问题,风险受到环境,遗传和生活方式因素的影响.
现有的中风诊断方法在及时治疗方面存在局限性.
动脉样硬化是缺血性中风的主要原因.

研究的目的:

调查C-反应蛋白 (CRP),骨质素 (OPN),骨质保护素 (OPG) 和乳素类氧化低密度脂蛋白受体1 (LOX1) 与动脉样硬化和中风有关的临床意义和诊断效用.
加强中风的早期诊断和治疗策略.
探索这些生物标志物与动脉狭窄和中风风险的相关性.

主要方法:

对156名动脉狭窄导致缺血性中风的患者进行了回顾性分析.
数据收集包括病史,生活方式,血清标志物和并发症.
用多普勒超声波评估关动脉狭窄;分类斑块稳定性和狭窄程度.
使用二进制逻辑回归和支持矢量机器优化分析的生物标志物水平.

主要成果:

甲基C反应蛋白 (CRP) 和骨质保护蛋白 (OPG) 已被证明具有保护性作用,可以防止动脉封闭.
骨质素 (OPN) 和类似莱克的氧化低密度脂蛋白受体1 (LOX1) 被确定为中风的危险因素.
该研究强调了这些生物标志物的复杂相互作用在动脉样硬化和中风的背景下.

结论:

CRP和OPG可以作为保护性生物标志物,而OPN和LOX1则表明中风风险增加.
这些发现有助于了解中风病因和确定潜在的治疗点.
需要进一步的研究来验证这些生物标志物在中风管理中的诊断和治疗应用.

关键词:

在C-反应性蛋白质中.Carotid 动脉疾病动脉疾病类似莱克的氧化低密度脂蛋白受体1 骨质疏松素是一种骨质疏松素.骨质保护剂中的骨质保护剂预测建模的预测建模.血管病理学血管病理学

更多相关视频

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...